Cubist Systematic Strategies’s Entrada Therapeutics TRDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,160
| Closed | -$60.3K | – | 3007 |
|
|
2023
Q1 | $60.3K | Buy |
4,160
+3,755
| +927% | +$54.4K | ﹤0.01% | 2497 |
|
|
2022
Q4 | $5.48K | Sell |
405
-600
| -60% | -$8.11K | ﹤0.01% | 3123 |
|
|
2022
Q3 | $16K | Sell |
1,005
-869
| -46% | -$13.8K | ﹤0.01% | 3449 |
|
|
2022
Q2 | $23K | Buy |
+1,874
| New | +$23K | ﹤0.01% | 3656 |
|
|
2022
Q1 | – | Sell |
-11,090
| Closed | -$190K | – | 3752 |
|
|
2021
Q4 | $190K | Buy |
+11,090
| New | +$190K | ﹤0.01% | 3049 |
|